Pharmaceuticals
Traws Pharma Advances Bird Flu Treatment with Promising Phase 1 Results
Tivoxavir Marboxil Shows Potent Protection Against H5N1 in Preclinical and Early Clinical Studies Traws Pharma (TRAW), a clinical-stage biopharmaceutical company,...
Telomir Pharmaceuticals Advances Groundbreaking Research in Copper-Binding Therapies for Wilson’s Disease
Emerging Findings Position Telomir-1 as a Promising Solution for Copper Metabolism Disorders and Expand Its Potential Applications Telomir Pharmaceuticals (TELO),...
MIRA Pharmaceuticals Advances Ketamir-2: A Safe Step Forward in Neuropathic Pain Treatment
Favorable safety results pave the way for Phase 1 human trials in early 2025, offering hope for millions seeking non-addictive...
Telomir Pharmaceuticals Unveils Groundbreaking Results in Age-Reversal Science with Telomir-1
Preclinical Study Highlights Significant Longevity Benefits, Sets Stage for Human Trials Telomir Pharmaceuticals (Nasdaq: TELO) has announced groundbreaking preclinical results...
BioMarin Pharmaceuticals’ New Strategy Promises Strong Upside, Led by Voxzogo and Roctavian
Wedbush Sees Favorable Risk/Reward as BioMarin Targets Growth in Rare Disease Market BioMarin Pharmaceuticals (BMRN), a leader in rare disease...
Ligand Pharmaceuticals: A Diversified Biotech Powerhouse Poised for Growth
With Over 70 Royalty Streams, Ligand’s Unique Business Model Offers Compelling Opportunities for Investors Ligand Pharmaceuticals (LGND) is rapidly emerging...
Eli Lilly Introduces Affordable Version of Zepbound to Address Soaring Demand and Combat Counterfeit Drugs
New Single-Dose Vials of Zepbound Priced at Half the Cost Aim to Increase Access for Uninsured Patients Eli Lilly (LLY)...
Conduit Pharmaceuticals Secures Exclusive Licensing Agreement with AstraZeneca for Novel Therapeutics
Phase II Trials Set to Begin on Glucokinase Activators and Myeloperoxidase Inhibitor Targeting Autoimmune Disorders and Male Infertility Conduit Pharmaceuticals...
Corbus Pharmaceuticals: Pioneering Next-Generation Therapies in Cancer and Obesity
Revolutionary Treatments on the Horizon with CRB-701 and CRB-913 Corbus Pharmaceutical (CRPB), an early-stage clinical biotechnology company, is making significant...
TARS Pharmaceuticals: XDEMVY Eye Drops Set for Strong Performance in 2Q24 Amid Strategic Sales Expansion
Anticipated Growth in XDEMVY Sales, Sales Force Expansion, and Promising Pipeline Signal a Bright Future for TARS Pharmaceuticals As we...
